MannKind Corp (NASDAQ:MNKD)

biotech

Are Investors Signaling Optimism in Biotechs Through Short Interest?

The short interest data are out for the November 28 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
intelinside

The 5 Most Shorted Stocks on the Nasdaq

Among the most heavily shorted stocks traded on the Nasdaq between the November 14 and November 28 settlement dates, only BlackBerry saw a significant rise in short interest. The number ...
Read Full Story »
payoff

MannKind Sees More Insider Selling

MannKind Corp. (NASDAQ: MNKD) saw its shares trading lower on Thursday, on what was a day with little or no real news from the company. The culprit may simply be ...
Read Full Story »
DNA

Mixed Readings For Biotech Short Interest

The short interest data are out for the November 14 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Biotechnology word cloud

Biotech Short Interest Becomes Stock Specific (Updated)

The short interest data are out for the October 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Intel logo

The 5 Most-Heavily Shorted Nasdaq Stocks

Surges in short interest in Intel and Comcast between the October 15 and October 31 settlement dates made sure they remained near the top of the list of most shorted ...
Read Full Story »
462542665

MannKind Spending Trends See Improvements

MannKind Corp. (NASDAQ: MNKD) reported its third-quarter financial results on Monday morning. 24/7 Wall St. was not expecting any major insight or inflection point from this report because it is ...
Read Full Story »
Biotechnology word cloud

Biotech Short Interest Becomes Stock Specific

The short interest data are out for the October 15, settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
health care

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

There had been some brief hopes that the worst was over for struggling MannKind Corp. (NASDAQ: MNKD). It turns out that not all great FDA approvals end up being great ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AIG, Align Tech, Cliffs, Cyber-Ark, MannKind, Micron and More

Stocks were lower on Monday morning after IBM issued a spoiler alert on its earnings report. Last week's bounce has shown again that investors still are willing to keep buying ...
Read Full Story »
Biotechnology word cloud

Short Interest in Biotech Becomes Company Specific

The short interest data are out for the end of September settlement date. Biotech companies are considered a riskier group of stocks with big upside and big downside. FDA rulings ...
Read Full Story »
Apple Watch intro

Apple Slips From 5 Most Shorted Nasdaq Stocks

In the wake of the successful launch of the new iPhones, short sellers got out of the way of Apple. Its short interest plunged nearly 30% between the September 15 ...
Read Full Story »
research

Short Sellers Make Moves in Key Biotech Stocks

The short interest report is out for the September 15 settlement date, and here 247 Wall St. has decided to focus on the biotech sector. Short sellers are often active ...
Read Full Story »
Biotechnology word cloud

Short Sellers Remain Vigilant Against Biotechs

The short interest report is out for the August 29 settlement date, and 24/7 Wall St. is focusing on the biotech sector. Short sellers are often active in biotech stocks, ...
Read Full Story »
biotech

Rising Short Interest in Biotech Stocks

The short interest data is out for the August 15 settlement date. Short sellers might be inclined to bet against biotech companies because of their volatile behavior on the charts, ...
Read Full Story »